BioPharmSignal logoBioPharmSignal

Biotech News

Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

biote Corp (BTMD)biote Corp2026-06-25 13:46 ESTEarnings

IRVING, Texas --(BUSINESS WIRE)--Feb. 25, 2026-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients’ lives by providing hormone replacement therapy and healthy aging solutions, today announced the Company will provide fourth quarter and

Open original release

Related news

BTMDbiote Corp2026-06-25 13:46 EST

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

BTMDbiote Corp2026-06-25 13:46 EST

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports First Quarter 2026 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports First Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Names Rich Barrera to Board of Directors

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports Second Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports Third Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Nearly 40% of Women Say They were Misdiagnosed During Perimenopause, National Survey Reveals

View all latest news

biote Corp

biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

BTMDbiote Corp2026-06-26 12:45 EST

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

BTMDbiote Corp2026-06-26 12:45 EST

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

BTMDbiote Corp2026-06-26 12:45 EST

Biote Reports First Quarter 2026 Financial Results

BTMDbiote Corp2026-06-26 12:45 EST

Biote Reports First Quarter 2025 Financial Results

BTMDbiote Corp2026-06-26 12:45 EST

Biote Names Rich Barrera to Board of Directors

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States